Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11039676 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL226936 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL4004633 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL3708731 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL3708709 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL6048331 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL8732941 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL11423768 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TSHRCYP2C19USP2 | |
| SCHEMBL18249750 | 0.96 | ALDH1A1 (0.40) | ALDH1A1TSHRCYP2C19 | |
| SCHEMBL4612532 | 0.95 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 146 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112251240-B | Quaternary ammonium salt ionic liquid crystal polymer with temperature control electronic switch performance and preparation method and application thereof | 东北大学 | 2022-04-12 | — | — | CN | claimed |
| EP-1660507-B2 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | MILLENNIUM PHARM INC (US) | 2017-01-04 | — | — | EP | claimed |
| EP-1660507-B9 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2010-03-24 | — | — | EP | claimed |
| EP-1660507-B1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2009-08-05 | — | — | EP | claimed |
| EP-1658255-B1 | PROTEASOME INHIBITORS AND METHODS OF USING THE SAME | CEPHALON INC (US) | 2009-02-18 | — | — | EP | claimed |
| US-20060004151-A1 | Copolymers containing indan moieties and blends thereof | GENERAL ELECTRIC COMPANY | 2006-01-05 | — | — | US | claimed |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-05-19 | — | — | US | claimed |
| JP-57122051-A | — | — | None | — | — | JP | disclosed |
| JP-2308813-A | — | — | None | — | — | JP | disclosed |
| JP-4279537-A | — | — | None | — | — | JP | disclosed |
| EP-3981818-B1 | EPOXY RESIN CURING AGENT, EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, AND FIBER-REINFORCED COMPOSITE MATERIAL | MITSUBISHI GAS CHEMICAL CO (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20260001764-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO.,LTD. (JP) | 2026-01-01 | — | — | US | disclosed |
| US-20250388468-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | IDEMITSU KOSAN CO.,LTD. (JP) | 2025-12-25 | — | — | US | disclosed |
| JP-H04279537-A | PRODUCTION OF BICYCLOHEXYLDIOL | NEW JAPAN CHEM CO LTD | 1992-10-05 | — | — | JP | disclosed |
| JP-H02308813-A | POLYESTER OF BICYCLOHEXANEDIOL | CHISSO CORP | 1990-12-21 | — | — | JP | disclosed |
| EP-0340655-A2 | Compositions comprising thermally incompatible polymers | HIMONT ITALIA S.r.l. (IT) | 1989-11-08 | — | — | EP | disclosed |
| US-4702748-A | AGAINST GUM FORMATION BY ADDING CYCLOHEXANOL | NORTHEASTERN UNIVERSITY (US) | 1987-10-27 | — | — | US | disclosed |
| JP-S57122051-A | PREPARATION OF(1,1'-BICYCLOHEXYL)-1-CARBOXYLIC ACID 2-(DIETHYLAMINO)ETHYL ESTER | KAWAKEN FINE CHEM CO LTD | 1982-07-29 | — | — | JP | disclosed |
| US-4340768-A | COPPER CATALYZED HYDROLYSIS OF 4,4*-DIBROMO BIPHENYL | HODOGAYA CHEMICAL CO., LTD. (JP) | 1982-07-20 | — | — | US | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001764-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | BRAF, JAK1, SAV1 | ALDH1A1 718/4885TSHR 884/4885CYP2C19 2230/4885 |
| US-20050107307-A1 | Proteasome inhibitors and methods of using the same | PSMB11, PSMB5, PSMB6 | ALDH1A1 3935/4885TSHR 4250/4885CYP2C19 4493/4885 |
| US-20250388468-A1 | METHOD FOR PRODUCING SULFIDE SOLID ELECTROLYTE | JAK1, JAK2, SLC6A12 | ALDH1A1 932/4885TSHR 832/4885CYP2C19 2116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.